Latest
08.24.2021
Atea Pharmaceuticals Announces Publication of Data Highlighting AT-752’s Potent In Vitro and In Vivo Activity Against Dengue and O
Read Article
06.30.2021
Roche and Atea's small, early data peek sees experimental COVID drug slash viral load in hospital patients
Read Article
06.02.2021
CalciMedica Publishes Positive Data from Phase 2a Study of Auxora in Patients with Acute Pancreatitis and Announces First Patients
Read Article
10.29.2020
COVID-19 viral biotech Atea Pharmaceuticals prices upsized IPO at $24 high end
Read Article